BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 27134035)

  • 1. C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
    Xiao S; MacNair L; McLean J; McGoldrick P; McKeever P; Soleimani S; Keith J; Zinman L; Rogaeva E; Robertson J
    Brain Res; 2016 Sep; 1647():43-49. PubMed ID: 27134035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Vatovec S; Kovanda A; Rogelj B
    Neurobiol Aging; 2014 Oct; 35(10):2421.e1-2421.e12. PubMed ID: 24836899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.
    Stepto A; Gallo JM; Shaw CE; Hirth F
    Acta Neuropathol; 2014 Mar; 127(3):377-89. PubMed ID: 24366528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion.
    Waite AJ; Bäumer D; East S; Neal J; Morris HR; Ansorge O; Blake DJ
    Neurobiol Aging; 2014 Jul; 35(7):1779.e5-1779.e13. PubMed ID: 24559645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum.
    Cruts M; Gijselinck I; Van Langenhove T; van der Zee J; Van Broeckhoven C
    Trends Neurosci; 2013 Aug; 36(8):450-9. PubMed ID: 23746459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and molecular mechanism of frontotemporal lobar degeneration/amyotrophic lateral sclerosis with repeat expansion mutation in C9orf72.
    Ishiura H; Tsuji S
    J Neurogenet; 2015; 29(2-3):85-94. PubMed ID: 26540641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion.
    Sareen D; O'Rourke JG; Meera P; Muhammad AK; Grant S; Simpkinson M; Bell S; Carmona S; Ornelas L; Sahabian A; Gendron T; Petrucelli L; Baughn M; Ravits J; Harms MB; Rigo F; Bennett CF; Otis TS; Svendsen CN; Baloh RH
    Sci Transl Med; 2013 Oct; 5(208):208ra149. PubMed ID: 24154603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration.
    Ohki Y; Wenninger-Weinzierl A; Hruscha A; Asakawa K; Kawakami K; Haass C; Edbauer D; Schmid B
    Mol Neurodegener; 2017 Jan; 12(1):6. PubMed ID: 28088213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of C9orf72 hexanucleotide repeat expansion leads to formation of RNA foci and dipeptide repeat proteins but does not influence autophagy or proteasomal function in neuronal cells.
    Leskelä S; Huber N; Hoffmann D; Rostalski H; Remes AM; Takalo M; Hiltunen M; Haapasalo A
    Biochim Biophys Acta Mol Cell Res; 2021 Jun; 1868(7):119021. PubMed ID: 33775797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.
    Todd TW; Petrucelli L
    J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
    Wen X; Westergard T; Pasinelli P; Trotti D
    Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.
    Gitler AD; Tsuiji H
    Brain Res; 2016 Sep; 1647():19-29. PubMed ID: 27059391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of DNA G-quadruplex species forming from C9ORF72 G4C2-expanded repeats associated with amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Šket P; Pohleven J; Kovanda A; Štalekar M; Župunski V; Zalar M; Plavec J; Rogelj B
    Neurobiol Aging; 2015 Feb; 36(2):1091-6. PubMed ID: 25442110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
    Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
    Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.
    Mori K; Weng SM; Arzberger T; May S; Rentzsch K; Kremmer E; Schmid B; Kretzschmar HA; Cruts M; Van Broeckhoven C; Haass C; Edbauer D
    Science; 2013 Mar; 339(6125):1335-8. PubMed ID: 23393093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drosha inclusions are new components of dipeptide-repeat protein aggregates in FTLD-TDP and ALS C9orf72 expansion cases.
    Porta S; Kwong LK; Trojanowski JQ; Lee VM
    J Neuropathol Exp Neurol; 2015 Apr; 74(4):380-7. PubMed ID: 25756586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
    Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
    Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy.
    Cooper-Knock J; Higginbottom A; Stopford MJ; Highley JR; Ince PG; Wharton SB; Pickering-Brown S; Kirby J; Hautbergue GM; Shaw PJ
    Acta Neuropathol; 2015 Jul; 130(1):63-75. PubMed ID: 25943887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
    Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
    Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis.
    Xiao S; MacNair L; McGoldrick P; McKeever PM; McLean JR; Zhang M; Keith J; Zinman L; Rogaeva E; Robertson J
    Ann Neurol; 2015 Oct; 78(4):568-83. PubMed ID: 26174152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.